Fake Drugs Worth ₹ 27.91 Lakh Sent Back To Baddi From Agra, Seized

Solan : A consignment of spurious drugs having a face value of ₹ 27,91,445, manufactured by Baddi-based Trizal Formulation in the name of three renowned companies, was sent back to Baddi by a transport company from Agra following the directions of local drugs officials.

The drugs in 12 boxes had been couriered by kingpin of the spurious drug racket Mohit Bansal on November 21, a day before his arrest, to his wholesale firm MH Pharma in Agra. The officials today seized the consignment from the godown of the transport company TCI in Baddi, said State Drugs Controller Navneet Marwaha.

The Drugs Control Administration (DCA) had alerted the Uttar Pradesh DCA about this consignment on December 1. The consignment had remained undelivered as Bansal’s firm was sealed after the spurious drug racket was detected. The drugs were lying with the TCI in Agra.

“The recovered drugs comprise 1,77, 300 spurious tablets of different brands — Montair- 10, Roseday-10 and Glimisave-M2 tablets. The transport agency was directed to return the consignment as it purportedly contained spurious drugs. Two Drugs Inspectors escorted the transport vehicle from Agra to Baddi to avoid any tampering.”

Marwaha added that the arrest of the accused and timely action against the wholesale firm at Agra by the HP Drugs Control Department prevented the sale of spurious tablets.

The seized drugs comprise drugs used for common ailments. Roseday-10 is used to lower cholesterol, Glimisave-M2 is an anti-diabetic drug and Montair-10 is used by asthma patients. These carried the name of leading companies like Cipla, Eris and USV Private Limited.

Bansal was arrested with a cache of spurious drugs in his car on November 22 near the inter-state barrier at Baddi along with his two associates Atul Gupta and Vijay Kaushal.

  • Related Posts

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi